The highlight of each edition will now be our What's Hot in the Literature section, featuring curated trending journal articles with concise summaries and commentary from our Editorial Board members. These brief reads aim to kickstart your week with global gastroenterology highlights, allowing you to explore further at your convenience. We believe this refreshed approach will prove valuable to you and your colleagues, enabling a more connected and informed experience within the global gastroenterology community.
Polyp Detection at Colonoscopy – is AI better than 2 I’s?
Prof. Eamonn Quigley (USA) | 2 December 2024
Polypectomy – going cold
Prof. Eamonn Quigley (USA) | 18 November 2024
EUS-guided therapy improves outcomes of endoscopic gastric varix treatment
Prof. Mark Topazian (USA) | 4 November 2024
Mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
Prof. Ahad Eshraghian (Iran) | 21 October 2024
Gastric cancer is still common worldwide and can be predicted and prevented
Prof. Eamonn Quigley (USA) | 7 October 2024
Risk of TB and HBV reactivation with ustekinumab therapy
Prof. Mark Topazian (USA) | 23 September 2024
Eradication of Helicobacter pylori does not increase risk of esophageal adenocarcinoma
Prof. Eamonn Quigley (USA) | 9 September 2024
Trainee involvement does not increase the risk of post-ERCP pancreatitis
Prof. Kavel Visrodia (USA) | 9 September 2024
Supplementing taurine may play an important role in anti-cancer therapy
Prof. Zikai Wang (China) | 26 August 2024
Extended mesenteric resection in Crohn’s disease: Not spicy enough
Prof. Vishal Sharma (India) | 26 August 2024
Colonoscopy in the Real World
Prof. Eamonn Quigley (USA) | 12 August 2024
Microbiome Signatures for Colorectal Cancer (CRC) – dealing with confounding variables to find the real message
Prof. Zikai Wang (China) | 12 August 2024
Resmetirom in MASH/NASH with Liver Fibrosis
Prof. Ahad Eshraghian (Iran) | 29 July 2024
Risankizumab versus Ustekinumab for Crohn's Disease: When less is more
Prof. Vishal Sharma (India) | 29 July 2024
A new gastric cancer-producing pathogen? Streptococcus anginosus could promote gastric inflammation, atrophy, and tumorigenesis
Prof. Zikai Wang (China) | 15 July 2024
Diet in Infancy and Risk of IBD
Prof. Eamonn Quigley (USA) | 1 July 2024
Gastric Cancer: A Review of Risk Factors and New Insights into Treatment
Prof. Hany Dabbous (Egypt) | 1 July 2024
An open-label randomized-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
Prof. Evaristus Sunday Chukwudike (Nigeria) | 17 June 2024
Yoga for bowel preparation before colonoscopy
Prof. Vishal Sharma (India) | 17 June 2024
Early Initiation of Biologics and Disease Outcomes in Adults and Children with Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort
Dr. Jonathan O'Donnell (Australia) | 3 June 2024
Oral vonoprazan appears equivalent to IV PPI for prevention of peptic ulcer rebleeding
Prof. Mark Topazian (USA) | 3 June 2024
Tryptophan metabolites produced by the gut microbiome protect against enteric pathogens
Prof. Zikai Wang (China) | 20 May 2024
For hepatitis C access is the key to success
Prof. Eamonn Quigley (USA) | 20 May 2024
Vedolizumab and ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in-utero
Dr. Jonathan O'Donnell (Australia) | 6 May 2024
The Burden of Waste Generated by Endoscopy Units
Prof. Eamonn Quigley (USA) | 6 May 2024
Reverse metabolomics: new method for biomarker discovery in Crohn’s disease
Prof. Zikai Wang (China) | 22 April 2024
Recycled Hemodialysis Membranes Dramatically Reduce the Incidence off Water-Borne Diarrheal Illness
Prof. Eamonn Quigley (USA) | 22 April 2024
Which stents are better for endoscopic management of pancreatic necrosis: metal or plastic?
Prof. Kavel Visrodia (USA) | 8 April 2024
Seladelpar in Primary Biliary Cholangitis
Prof. Ahad Eshraghian (Iran) | 8 April 2024
Nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
Prof. Ahad Eshraghian (Iran) | 25 March 2024
Should patients with pyogenic liver abscess be screened for colorectal cancer?
Prof. Mark Topazian (USA) | 25 March 2024
Coconut water for ulcerative colitis: A (low-cost) biological of a different kind
Prof. Vishal Sharma (India) | 11 March 2024
Glucagon not helpful for food impactions
Prof. Eamonn Quigley (USA) | 11 March 2024
Primary Surgery vs. Anti-TNF in Crohn’s
Prof. Mark Topazian (USA) | 26 February 2024
Global Trends in GI Diseases – The Good News and the Bad News
Prof. Eamonn Quigley (USA) | 26 February 2024
JAK inhibitor effective in Crohn’s disease
Prof. Eamonn Quigley (USA) | 12 February 2024
Where We Miss Cancers During Colonoscopy
Prof. Mark Topazian (USA) | 12 February 2024
Nutrition in cirrhosis: recommend a bedtime snack
Prof. Mark Topazian (USA) | 29 January 2024
Endoscopic removal of Gastrointestinal Stromal Tumors (GIST)
Prof. Hany Dabbous (Egypt) | 29 January 2024
Early surgery for Crohn's disease
Prof. Vishal Sharma (India) | 15 January 2024
Which Africans with chronic hepatitis B should receive antivirals?
Prof. Mark Topazian (USA) | 15 January 2024